In these inflammatory pathological conditions, the multiligand receptor for advanced glycation end-products (RAGEs) is driven by aberrant cross-communication with the impairment of insulin/IGFs in modulating the gene transcription and protein translation in cancer [14]. Here, INS is linked to cancer.